Essential oils isolated from six Philippine plant species, namely Alpinia brevilabris C. Presl, Alpinia cumingii K. Schum., Alpinia elegans (C. Presl) K. Schum., Callicarpa micrantha Vidal, Cinnamomum mercadoi S. Vidal, and Piper quinqueangulatum Miq. were assessed for their in vitro growth-inhibitory effect against pneumonia causing bacteria (Haemophilus influenzae, Streptococcus pneumoniae, and Staphylococcus aureus) using the broth microdilution volatilization method. Additionally, a modified thiazolyl blue tetrazolium bromide assay was performed for evaluation of their cytotoxic activity to human lung cells. All essential oils exhibited some antibacterial efficacy in liquid phase; however, only A. cumingii oil was active in the vapour as well. Both A. cumingii and A. elegans oils showed the most effective antibacterial potential against H. influenzae in liquid medium with the minimum inhibitory concentration of 256 µg/mL. Using dual-column/dual-detector system GC/MS analysis, hedycaryol, β-pinene, caryophyllene epoxide, aristolochene, borneol, and linalool were identified as the major components of A. brevilabris, A. cumingii, A. elegans, C. micrantha, C. mercadoi, and P. quinqueangulatum leaves oils, respectively.
Pneumonia, acute respiratory infection caused by bacterial pathogens such as Haemophilus influenzae, Streptococcus pneumoniae, and Staphylococcus aureus, is one of the leading causes of morbidity and mortality in developing countries, including the Philippines. The majority of severe episodes occurs in children under five years, the elderly and immuno-compromised individuals [1] . A timely antibiotic therapy can reduce its fatal cases; nevertheless, access to the health services is the most important health problem in the Philippines [2a] . In this area, about 8,900 children die from pneumonia every year [1] , whereas only 50% of them are treated with antibiotics [2b].
The plant essential oils (EOs) are of great potential for development of novel antimicrobial preparations [3] . Since the presence of volatile compounds is characteristic for some plant taxa, chemotaxonomic research is frequent approach to their exploration. Due to the volatility of EOs, they are suitable for inhalation therapy, which is an effective way for the healing of respiratory ailments such as pneumonia. Their vapours can act directly on the site of infection in the respiratory system and simultaneously restricts systemic exposure, degradation of active components in the gastrointestinal tract, and associated toxicity [4] . In addition, it is more difficult for bacteria to develop resistance to these chemically diverse multicomponent mixtures than to single-ingredient conventional antibiotics [5] . During the last few years, several inhalation devices for EOs have been developed and patented [6] .
In the Philippines, traditional medicine has been in practice for more than a thousand years and it still plays an important role in primary health care at present [2c] . The Philippine archipelago is a centre of biodiversity where a large number of endemic plants has been reported to exhibit medicinal properties including plant species belonging to the essential oils-bearing families such as Zingiberaceae, Piperaceae, and Lauraceae [7] . Nevertheless, scientific validation and identification of many Philippine medicinal plants as well as determination of their anti-infective properties, chemical composition, and safety are needed. Recently, several in vitro studies have investigated antimicrobial potential of EOs derived from Philippine plant species that are easily available in traditional markets and in wild nature [8] . However, no experiments had determined antibacterial potential of their vapours against pathogens causing pneumonia until now.
In this article, we report examination of in vitro growth-inhibitory effect of EOs from six less known Philippine aromatic plants, namely Alpinia brevilabris C. Presl, Alpinia cumingii K. Schum., Alpinia elegans (C. Presl) K. Schum., Callicarpa micrantha Vidal, Cinnamomum mercadoi S. Vidal, and Piper quinqueangulatum Miq., against pneumonia causing bacteria in liquid and vapour phase by using novel broth microdilution volatilization method recently developed by our team [9] . Additionally, the cytotoxicity and chemical composition of tested EOs were analysed with the aim In this study, the EOs were obtained by hydrodistillation from plant species belonging to typical essential oil-bearing plant families, namely A. brevilabris (Zingiberaceae), A. cumingii (Zingiberaceae), A. elegans (Zingiberaceae), C. micrantha (Lamiaceae), C. mercadoi (Lauraceae), and P. quinqueangulatum (Piperaceae). According to our best knowledge, the EOs from these species were isolated for the first time.
There is no previous literature reporting any antimicrobial effect for plant species tested here, except study on C. mercadoi bark and root crude extract, which showed week inhibitory activity against S. aureus [10] . However, the Whereas data on inhalation toxicity of the EOs tested here are completely missing, several studies evaluated toxicity of taxonomically related species have previously been published. Contact toxicity was assessed for EO of Alpinia purpurata inflorescence since there was no mortality at any concentrations tested [13] . Another in vivo tests of acute oral toxicity in rodents showed that EOs from Piper glabratum leaves did not cause death or signs of toxicity up to dose of 1,000 mg/kg [14] . In contrast, Cinnamomum zeylanicum oil indicated significant cytotoxic effect in normal rat fibroblast F2408 over 15 µg/mL dose. However, treatment of the normal F2408 cells with the C. zeylanicum oil at varying periods did not cause any time-dependent cytotoxicity [15] . 
Carbonylic compounds
Hexan-2-one cumingii, and P. quinquangulatum oils. With the aim to achieve a higher quality identification, the EOs were conducted on two columns with different polarities, non-polar HP-5MS and mid-polar DB-17MS, when ten, six, eleven, sixteen, fifteen, and nine additional compounds were identified using DB-17MS column in A. brevilabris, A. cumingii, A. elegans, C. micrantha, C. mercadoi, and P. quinqueangulatum oils, respectively.
Higher isoprenoids
In summary, this is the first report on antibacterial activity and chemical composition of EOs isolated from A. brevilabris, A. cumingii, A. elegans, C. micrantha, C. mercadoi, and P. quinqueangulatum. Although all EOs tested exhibited certain growth-inhibitory effect in broth against H. influenzae and S. aureus, only A. cumingii was active in vapour phase against H. influenzae. However, due to the moderate toxic effect to human lung cells, its usability as inhalation preparation seems to be limited. Nevertheless, further research focused on in vivo evaluation will be necessary to carry out in order to verify its potential for application in the therapy of respiratory infections. EOs isolation: EOs were obtained by hydrodistillation of dried leaves in 1 L of distilled water for 3 h using a Clevenger-type apparatus (Merci) according to the European Pharmacopoeia [18] . The EOs were stored in sealed glass vials at 4°C.
Experimental

Bacterial strains and culture media:
The following American Type Culture Collection (ATCC) strains were used: Haemophilus influenzae ATCC 49247, Staphylococcus aureus ATCC 29213, and Streptococcus pneumoniae ATCC 49619. Cultivation and assay media (broth/agar) were Mueller-Hinton (MH) complemented by yeast extract and Haemophilus Tested Medium (H. influenzae), MH (S. aureus), and Brain Heart Infusion (S. pneumoniae). Broths pH were equilibrated to final value 7.6 using Trizma base (SigmaAldrich). All microbial strains and cultivation media were purchased from Oxoid. Stock cultures of bacteria were cultivated in appropriate medium at 37°C for 24 h prior the testing and then a turbidity of the bacterial suspension was adjusted to 0.5 McFarland standard using Densi-La-Meter II (Lachema) to get the final concentration of 10 7 CFU/mL. The susceptibilities of H. influenzae, S. aureus, and S. pneumoniae to ampicillin (≥84.5%), oxacillin (≥86.3%), and amoxicillin (≥90%), respectively (purchased from Sigma-Aldrich), were checked as positive antibiotic controls [19] .
Antimicrobial assay: The antibacterial potential of plant EOs in liquid and vapour phase was determined using a broth microdilution volatilization method [9] . The experiments were performed in 96-well immune plates, covered by tight-fitting lids with flanges designed to reduce evaporation (SPL Life Sciences). Briefly, 30 µL of agar was pipetted into every flange on the lid, except the outermost flanges, and inoculated with bacterial suspension (5 µL). In the second part of this method, each sample of EOs was dissolved in DMSO (Sigma-Aldrich) at maximum concentration of 1%, and diluted in an appropriate broth medium. Seven two-fold serially diluted concentrations of samples starting from 1,024 µg/mL were prepared for all EOs. The plates were then inoculated with bacterial suspensions using a 96-pin multi-blot replicator (National Institute of Public Health). The wells containing inoculated and non-inoculated broth were prepared as growth and purity controls simultaneously. Finally, clamps (Lux Tool) were used for fastening the plate and lid together, with the handmade wooden pads for better fixing. The microtiter plates were incubated at 37°C for 24 h. The minimum inhibitory concentrations (MICs) were evaluated by visual assessment of bacterial growth after colouring of a metabolically active bacterial colony with thiazolyl blue tetrazolium bromide dye (MTT) (Sigma-Aldrich) at a concentration of 600 µg/mL when the interface of colour change from yellow and purple (relative to that of colours in control wells) was recorded in broth and agar. The MIC values were determined as the lowest concentrations inhibiting bacterial growth compared with the compound-free control and expressed in µg/mL (in the case of vapour phase also in µg/cm 3 , where 256; 128; 64; 32; 16; 8; 4; and 2 µg/cm 3 are real values for 1,024; 512; 256; 128; 64; 32; 16; and 8 µg/mL, respectively). The DMSO assayed as the negative control at concentration 1% did not inhibit any of the strains tested either in broth or agar media. All experiments were carried out in triplicate in three independent experiments and results were expressed as median/modal MICs values.
Cell culture: Lung fibroblast cells MRC-5 purchased directly from ATCC were propagated in Eagle's Minimum Essential Medium (EMEM) supplemented with 10% foetal bovine serum (FBS), 2 mM glutamine, 10 µL/mL non-essential amino acids, and 1% penicillinstreptomycin solution (10,000 units/mL of penicillin and 10 mg/mL of streptomycin), all these components purchased from SigmaAldrich. The cells were preincubated in 96-well microtiter plates at density of 2.5 × 10 3 cells per well for 24 h in a humidified incubator under atmosphere of 5% CO 2 at 37°C.
Cytotoxicity assay:
The modified method for toxicity assessment of volatile agents [12] previously described by Mosmann [20] was used. Twelve two-fold serially diluted concentrations starting from 512 µg/mL of EOs dissolved in DMSO were prepared. The microtiter plates were covered by EVA capmats TM under humidified atmosphere of 5% CO 2 and cultivated for 72 h at 37°C. Thereafter, MTT (1 mg/mL) in EMEM solution was added to each well and plates were incubated for an additional 2 h under the same conditions. The media were removed and intracellular formazan product was dissolved in 100 µL of DMSO. The solvent used did not affect the viability of the lung cells at the concentrations tested. The absorbance was measured at 555 nm and the percentage of viability was calculated when compared to an untreated control. The results of the cytotoxic effect were expressed as IC 50 in µg/mL. The levels of cytotoxicity were classified as cytotoxic (IC 50 < 2 µg/mL), moderately cytotoxic (IC 50 2-89 µg/mL), and non-toxic (IC 50 > 90 µg/mL) [21] . Furthermore, 80% inhibitory concentration of proliferation (IC 80 ) was calculated as equivalent to MIC endpoint usually defined as 80% bacterial growth inhibition and therapeutic indices (TI) were defined as the ratio of IC 50 or IC 80 and MIC values.
GC/MS analysis:
For determination of the main components of EOs tested, GC/MS analysis was carried out using dual-column/dualdetector gas chromatograph system Agilent GC- . The RIs were calculated for compounds separated by HP-5MS column using the retention times of n-alkanes series C9-C29 (Sigma-Aldrich). For each EO analysed, the final number of compounds was calculated as the sum of components simultaneously identified using both columns and the remaining constituents identified by individual columns only. The relative percentage contents of EO components were determined by FID and indicated for both columns.
